✓ Last verified: March 4, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: Stony Brook Psychiatric Associates operates within the Stony Brook University Medicine system, offering intranasal ketamine therapy through their dedicated Treatment-Resistant Depression (TRD) Program. Led by Dr. Lucian Manu with a full team of psychiatrists, nurses, and technicians, this academic medical center provides ketamine treatment for patients who’ve tried two or more medications without adequate improvement.
Contact for pricing; Spravato may be insurance-covered
Insurance
Academic medical center; contact for accepted plans
KAP Available
TRD program with psychiatric support
Clinical Lead
Dr. Lucian Manu & TRD team
HealingMaps Take: Stony Brook’s academic medical center backing sets this apart from private ketamine clinics—patients get university-level psychiatric care with research-informed protocols. The TRD Program is specifically designed for patients who’ve exhausted conventional antidepressants, and the potential for insurance coverage on Spravato makes this a more financially accessible option for qualifying Long Island patients.
Market Position: Stony Brook Psychiatric Associates is a Spravato-certified clinic in the Psychiatric metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Is Stony Brook Psychiatric Associates Right for You?
✓ Choose Stony Brook Psychiatric Associates if:
You have commercial insurance and a documented treatment-resistant depression diagnosis (Spravato pathway)
You want academic-medical-center protocols and clinical-trial-grade oversight
✗ Look elsewhere if:
You’re seeking cash-pay IV ketamine instead of insurance-billed Spravato
You want ketamine-assisted psychotherapy (KAP) with integrated talk therapy
You need same-week appointments — Spravato prior authorization typically takes 1–3 weeks
Estimate your out-of-pocket range based on patient-reported pricing and HealingMaps proprietary clinic data.
Estimated per session
$525–$900
Range: $450–$1,500/session
Estimated total program
$3,150–$5,400
Range: $2,700–$9,000/6-session series
Your estimate vs. national patient-reported medianBased on national tracking, adjusted for Manhattan, NY market
Select a treatment type to see pricing context.
Get matched to verified clinics
A HealingMaps specialist will follow up within one business day with providers that match your estimate, protocol, and insurance situation.
✓ Request received.
A HealingMaps specialist will reach out within one business day with clinic matches based on your estimate. In the meantime, review the verified providers below.
Industry pricing reference. Stony Brook Psychiatric Associates has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
Protocol
Typical Industry Cost
Offered Here
IV Ketamine
$350–$650/session
—
Spravato (esketamine)
$0–$250 copay (insured)
✓ Yes
IM Ketamine
$250–$400/injection
—
KAP (with therapist)
$400–$1,200/session
—
At-home troches
$150–$300/month
—
What to Expect at Your First Stony Brook Psychiatric Associates Appointment
Initial intake call — Insurance verification, prior authorization workflow (Spravato requires documentation of failure on at least two antidepressant trials), and clinical eligibility check. Call (631) 444-2990 to schedule.
Medical evaluation — in-person or telehealth psychiatric assessment, vitals check, and review of current medications with the Stony Brook Psychiatric Associates clinical team.
First treatment session — supervised Spravato (intranasal esketamine) in a private treatment room, lasting approximately 90 minutes (40-minute session + 60 minutes monitoring). Sessions are held at 100 Nicolls Road, Stony Brook, NY 11794. You’ll have a comfortable chair or recliner, dim lighting, and direct medical monitoring throughout.
Recovery and follow-up — observation period after dosing, mood check-in with the clinical team, and scheduling your next session. Arrange for a ride home; do not drive for 24 hours after your Spravato session.
What to Ask on Your Stony Brook Psychiatric Associates Consult Call
How long has the Stony Brook Psychiatric Associates clinical team been delivering ketamine therapy, and what specialty training do your providers hold?
How long does Stony Brook Psychiatric Associates’s Spravato prior authorization typically take with my specific insurance plan, and what happens if it’s denied?
Which New York commercial insurers (Aetna, UnitedHealthcare, Empire BCBS, Oxford, Healthfirst) have you successfully obtained Spravato prior authorization through?
Does Stony Brook Psychiatric Associates require a referral from a current treating psychiatrist, and how do you handle outside-prescriber medication-management coordination?
What does Stony Brook Psychiatric Associates recommend for patients who don’t respond to the standard 6-session acute series?
Patient Questions about Stony Brook Psychiatric Associates
This 2-question summary is matched to the protocols and conditions Stony Brook Psychiatric Associates treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Does Stony Brook Psychiatric Associates offer Spravato (esketamine)?
Yes — Stony Brook Psychiatric Associates offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Is Stony Brook Psychiatric Associates suited for treatment-resistant depression?
Stony Brook Psychiatric Associates treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
The Healing Maps Editorial Team has decades of experience across all facets of the psychedelic industry. From assessing studies and clinic research, to working with clinician's and clinics, we help provide data-backed information to psychedelic-curious individuals across the globe.
Leave a Reply